Acetazolamide can improve symptoms and signs in ion channel-related congenital myopathy. (2019)
Attributed to:
MICA: MRC Centre for Neuromuscular Diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/jnnp-2017-317849
PubMed Identifier: 29769250
Publication URI: http://europepmc.org/abstract/MED/29769250
Type: Journal Article/Review
Volume: 90
Parent Publication: Journal of neurology, neurosurgery, and psychiatry
Issue: 2
ISSN: 0022-3050